AKT signaling in ERBB2-amplified breast cancer

Title
AKT signaling in ERBB2-amplified breast cancer
Authors
Keywords
PI3K, mTOR, Trastuzumab, Targeted therapy, Drug resistance, AKT3
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 158, Issue -, Pages 63-70
Publisher
Elsevier BV
Online
2015-12-02
DOI
10.1016/j.pharmthera.2015.11.013

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started